MTOR and Alzheimer disease: Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits (Fig. 1) and lowered levels of Aβ42 (Fig. 2) in the PDAPP transgenic mouse model.